ImmuPharma Common Stock Total Equity vs Net Receivables Analysis

IMM Stock

1.19 0.24 16.78%

ImmuPharma PLC financial indicator trend analysis is infinitely more than just investigating ImmuPharma PLC recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether ImmuPharma PLC is a good investment. Please check the relationship between ImmuPharma PLC Common Stock Total Equity and its Net Receivables accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ImmuPharma PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Common Stock Total Equity vs Net Receivables

Common Stock Total Equity vs Net Receivables Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of ImmuPharma PLC Common Stock Total Equity account and Net Receivables. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between ImmuPharma PLC's Common Stock Total Equity and Net Receivables is -0.13. Overlapping area represents the amount of variation of Common Stock Total Equity that can explain the historical movement of Net Receivables in the same time period over historical financial statements of ImmuPharma PLC, assuming nothing else is changed. The correlation between historical values of ImmuPharma PLC's Common Stock Total Equity and Net Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock Total Equity of ImmuPharma PLC are associated (or correlated) with its Net Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Receivables has no effect on the direction of Common Stock Total Equity i.e., ImmuPharma PLC's Common Stock Total Equity and Net Receivables go up and down completely randomly.

Correlation Coefficient

-0.13

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Common Stock Total Equity

The total value of common stock equity held by shareholders, representing their ownership interest in the company.

Net Receivables

Most indicators from ImmuPharma PLC's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into ImmuPharma PLC current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ImmuPharma PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

The current year's Selling General Administrative is expected to grow to about 1.7 M, whereas Tax Provision is forecasted to decline to (522 K).

	2021	2022	2023	2024 (projected)
Interest Expense	2.4M	1.5M	2.0K	1.9K
Depreciation And Amortization	114.1K	117.6K	37.6K	35.7K

Interest Expense Depreciation And Amortization

ImmuPharma PLC fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Short Long Term Debt Total	Property Plant And Equipment Net	Accounts Payable	Net Receivables	Property Plant And Equipment Gross	Short Term Debt	Intangible Assets	Property Plant Equipment
Total Assets		-0.3	0.03	0.99	-0.93	0.35	0.92	0.17	-0.47	0.59	0.92	-0.19	-0.32	0.11	-0.16	0.37	0.96	-0.21	0.65	0.11	-0.3	0.22	-0.13	0.4	0.16	-0.19
Other Current Liab	-0.3		0.55	-0.38	0.26	-0.52	-0.27	-0.1	-0.18	-0.31	-0.27	0.61	0.74	-0.08	0.41	0.43	-0.3	0.58	-0.31	-0.15	0.33	-0.04	-0.03	-0.45	-0.35	0.54
Total Current Liabilities	0.03	0.55		-0.08	0.12	-0.65	-0.12	0.22	0.17	0.12	-0.12	0.74	0.73	0.17	0.6	0.76	-0.08	0.75	-0.18	0.47	0.73	0.11	0.53	-0.25	-0.71	0.74
Total Stockholder Equity	0.99	-0.38	-0.08		-0.92	0.38	0.91	0.21	-0.46	0.56	0.91	-0.24	-0.37	0.11	-0.18	0.24	0.95	-0.26	0.62	0.1	-0.36	0.2	-0.16	0.42	0.21	-0.24
Net Debt	-0.93	0.26	0.12	-0.92		-0.55	-1.0	0.06	0.65	-0.46	-1.0	0.39	0.45	0.19	0.41	-0.35	-0.96	0.41	-0.76	0.13	0.42	-0.09	0.28	-0.41	-0.44	0.37
Retained Earnings	0.35	-0.52	-0.65	0.38	-0.55		0.58	-0.59	-0.43	0.33	0.58	-0.96	-0.94	-0.18	-0.95	-0.1	0.54	-0.97	0.75	-0.42	-0.71	0.21	-0.59	0.45	0.81	-0.77
Cash	0.92	-0.27	-0.12	0.91	-1.0	0.58		-0.1	-0.63	0.48	1.0	-0.42	-0.47	-0.19	-0.44	0.38	0.97	-0.43	0.81	-0.13	-0.45	0.1	-0.3	0.44	0.46	-0.38
Non Current Assets Total	0.17	-0.1	0.22	0.21	0.06	-0.59	-0.1		0.41	-0.15	-0.1	0.56	0.38	0.04	0.68	-0.23	-0.09	0.55	-0.4	0.5	0.25	-0.34	0.4	0.11	-0.47	0.43
Non Currrent Assets Other	-0.47	-0.18	0.17	-0.46	0.65	-0.43	-0.63	0.41		-0.07	-0.63	0.31	0.23	0.14	0.43	-0.22	-0.6	0.31	-0.38	0.37	0.21	-0.12	0.25	0.1	-0.54	0.34
Other Assets	0.59	-0.31	0.12	0.56	-0.46	0.33	0.48	-0.15	-0.07		0.48	-0.26	-0.34	0.42	-0.1	0.4	0.6	-0.28	0.45	0.21	-0.13	0.52	-0.13	0.11	-0.22	-0.14
Cash And Short Term Investments	0.92	-0.27	-0.12	0.91	-1.0	0.58	1.0	-0.1	-0.63	0.48		-0.42	-0.47	-0.19	-0.44	0.38	0.97	-0.43	0.81	-0.13	-0.45	0.1	-0.3	0.44	0.46	-0.38
Common Stock Total Equity	-0.19	0.61	0.74	-0.24	0.39	-0.96	-0.42	0.56	0.31	-0.26	-0.42		0.97	0.21	0.92	0.28	-0.37	0.99	-0.59	0.44	0.65	-0.13	0.54	-0.35	-0.79	0.83
Common Stock Shares Outstanding	-0.32	0.74	0.73	-0.37	0.45	-0.94	-0.47	0.38	0.23	-0.34	-0.47	0.97		0.12	0.86	0.32	-0.45	0.97	-0.61	0.3	0.68	-0.15	0.5	-0.49	-0.72	0.79
Other Current Assets	0.11	-0.08	0.17	0.11	0.19	-0.18	-0.19	0.04	0.14	0.42	-0.19	0.21	0.12		0.28	0.03	0.07	0.19	-0.21	0.3	0.22	0.75	0.14	-0.22	-0.47	0.19
Other Stockholder Equity	-0.16	0.41	0.6	-0.18	0.41	-0.95	-0.44	0.68	0.43	-0.1	-0.44	0.92	0.86	0.28		0.08	-0.38	0.91	-0.71	0.44	0.63	-0.09	0.49	-0.42	-0.88	0.71
Total Liab	0.37	0.43	0.76	0.24	-0.35	-0.1	0.38	-0.23	-0.22	0.4	0.38	0.28	0.32	0.03	0.08		0.39	0.28	0.42	0.14	0.3	0.25	0.16	-0.06	-0.24	0.3
Total Current Assets	0.96	-0.3	-0.08	0.95	-0.96	0.54	0.97	-0.09	-0.6	0.6	0.97	-0.37	-0.45	0.07	-0.38	0.39		-0.39	0.77	-0.05	-0.4	0.29	-0.26	0.39	0.34	-0.34
Common Stock	-0.21	0.58	0.75	-0.26	0.41	-0.97	-0.43	0.55	0.31	-0.28	-0.43	0.99	0.97	0.19	0.91	0.28	-0.39		-0.6	0.47	0.71	-0.15	0.62	-0.39	-0.78	0.82
Short Long Term Debt Total	0.65	-0.31	-0.18	0.62	-0.76	0.75	0.81	-0.4	-0.38	0.45	0.81	-0.59	-0.61	-0.21	-0.71	0.42	0.77	-0.6		-0.17	-0.63	0.1	-0.4	0.64	0.58	-0.42
Property Plant And Equipment Net	0.11	-0.15	0.47	0.1	0.13	-0.42	-0.13	0.5	0.37	0.21	-0.13	0.44	0.3	0.3	0.44	0.14	-0.05	0.47	-0.17		0.4	-0.09	0.74	0.19	-0.55	0.7
Accounts Payable	-0.3	0.33	0.73	-0.36	0.42	-0.71	-0.45	0.25	0.21	-0.13	-0.45	0.65	0.68	0.22	0.63	0.3	-0.4	0.71	-0.63	0.4		0.11	0.76	-0.62	-0.63	0.51
Net Receivables	0.22	-0.04	0.11	0.2	-0.09	0.21	0.1	-0.34	-0.12	0.52	0.1	-0.13	-0.15	0.75	-0.09	0.25	0.29	-0.15	0.1	-0.09	0.11		-0.22	-0.16	-0.17	-0.13
Property Plant And Equipment Gross	-0.13	-0.03	0.53	-0.16	0.28	-0.59	-0.3	0.4	0.25	-0.13	-0.3	0.54	0.5	0.14	0.49	0.16	-0.26	0.62	-0.4	0.74	0.76	-0.22		-0.28	-0.44	0.54
Short Term Debt	0.4	-0.45	-0.25	0.42	-0.41	0.45	0.44	0.11	0.1	0.11	0.44	-0.35	-0.49	-0.22	-0.42	-0.06	0.39	-0.39	0.64	0.19	-0.62	-0.16	-0.28		0.35	-0.09
Intangible Assets	0.16	-0.35	-0.71	0.21	-0.44	0.81	0.46	-0.47	-0.54	-0.22	0.46	-0.79	-0.72	-0.47	-0.88	-0.24	0.34	-0.78	0.58	-0.55	-0.63	-0.17	-0.44	0.35		-0.73
Property Plant Equipment	-0.19	0.54	0.74	-0.24	0.37	-0.77	-0.38	0.43	0.34	-0.14	-0.38	0.83	0.79	0.19	0.71	0.3	-0.34	0.82	-0.42	0.7	0.51	-0.13	0.54	-0.09	-0.73

Click cells to compare fundamentals

ImmuPharma PLC Account Relationship Matchups

ImmuPharma PLC fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	5.8M	10.9M	6.0M	4.0M	2.7M	2.6M
Other Current Liab	104.3K	110.7K	158.8K	200.0K	768.5K	806.9K
Total Current Liabilities	531.9K	1.3M	1.6M	1.5M	1.7M	1.4M
Total Stockholder Equity	5.3M	9.7M	4.4M	2.5M	1.1M	1.0M
Net Debt	(1.3M)	(5.2M)	(1.6M)	(667.7K)	(208.5K)	(218.9K)
Retained Earnings	(40.2M)	(46.0M)	(56.6M)	(61.1M)	(64.1M)	(60.9M)
Cash	1.4M	5.9M	1.6M	667.8K	208.5K	198.1K
Non Current Assets Total	2.2M	3.5M	2.7M	1.6M	1.4M	1.4M
Non Currrent Assets Other	1.5M	2.6M	1.8M	772.1K	(1.0)	(1.05)
Cash And Short Term Investments	1.4M	5.9M	1.6M	667.8K	208.5K	198.1K
Common Stock Total Equity	13.3M	13.9M	16.7M	25.0M	28.8M	30.2M
Common Stock Shares Outstanding	153.5M	200.2M	251.2M	302.9M	362.0M	380.1M
Liabilities And Stockholders Equity	5.8M	10.9M	6.0M	4.0M	2.7M	2.6M
Other Current Assets	2.2M	1.6M	1.7M	1.5M	1.1M	1.3M
Other Stockholder Equity	27.3M	27.2M	27.2M	28.8M	29.3M	30.8M
Total Liab	531.9K	1.3M	1.6M	1.5M	1.7M	1.7M
Total Current Assets	3.6M	7.4M	3.3M	2.3M	1.3M	1.3M
Common Stock	16.7M	25.0M	28.5M	29.0M	29.8M	31.3M
Short Long Term Debt Total	26.8K	641.8K	700.0	111.0	99.9	94.91
Property Plant And Equipment Net	206.7K	411.6K	353.0K	389.7K	102.1K	181.9K
Accounts Payable	329.7K	418.1K	1.2M	1.1M	776.2K	760.8K
Net Receivables	709.1K	481.9K	1.1M	166.3K	685.7K	950.7K
Property Plant And Equipment Gross	206.7K	411.6K	1.1M	1.3M	192.3K	280.6K
Accumulated Other Comprehensive Income	5.0M	6.8M	8.7M	9.3M	6.0M	6.3M
Short Term Debt	26.8K	641.8K	700.0	111.0	99.9	94.91
Intangible Assets	479.0K	484.0K	477.6K	473.9K	447.6K	477.8K
Property Plant Equipment	164.7K	206.7K	411.6K	353.0K	405.9K	426.2K
Current Deferred Revenue	(175.4K)	(201.0K)	(427.7K)	(380.1K)	(437.1K)	(458.9K)
Non Current Liabilities Total	22.5K	531.9K	1.3M	1.2M	1.5M	0.0
Net Tangible Assets	5.2M	9.6M	3.9M	2.5M	2.8M	5.2M
Short Long Term Debt	98.3K	26.8K	641.8K	700.0	111.0	0.0
Capital Surpluse	18.7M	27.3M	27.2M	27.2M	31.3M	25.6M
Net Invested Capital	5.3M	10.3M	4.4M	2.5M	1.1M	1.0M
Net Working Capital	3.0M	6.2M	1.8M	887.6K	(321.9K)	(305.8K)
Capital Stock	16.7M	25.0M	28.5M	29.0M	29.8M	26.2M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Other Information on Investing in ImmuPharma Stock

Balance Sheet is a snapshot of the financial position of ImmuPharma PLC at a specified time, usually calculated after every quarter, six months, or one year. ImmuPharma PLC Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of ImmuPharma PLC and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which ImmuPharma currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

ImmuPharma Common Stock Total Equity vs Net Receivables Analysis

Common Stock Total Equity vs Net Receivables

Common Stock Total Equity vs Net Receivables Correlation Analysis

Correlation Coefficient

Common Stock Total Equity

Net Receivables

ImmuPharma PLC fundamental ratios Correlations

ImmuPharma PLC Account Relationship Matchups

High Positive Relationship

High Negative Relationship

ImmuPharma PLC fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in ImmuPharma Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Total Stockholder Equity	+ 0.99	Total Assets
Common Stock	+ 0.99	Common Stock Total Equity
Total Current Assets	+ 0.97	Cash
Total Current Assets	+ 0.97	Cash And Short Term Investments
Common Stock Shares Outstanding	+ 0.97	Common Stock Total Equity

Cash And Short Term Investments	- 1.0	Net Debt
Cash	- 1.0	Net Debt
Common Stock	- 0.97	Retained Earnings
Common Stock Total Equity	- 0.96	Retained Earnings
Total Current Assets	- 0.96	Net Debt
Other Stockholder Equity	- 0.95	Retained Earnings